Latest News

The CDPP’s Corporate Plan 2023–27 is now available.

The 2021-22 CDPP Annual Report was tabled in Parliament on Friday 28 October 20

The CDPP recently received an overall satisfaction score of 86 per cent from its biennial 2022 Partner Agency Survey.

The CDPP's 2022-26 Corporate Plan is now available.

The Attorney-General of New South Wales today announced the appointment of Ms Sarah McNaughton SC as a judge of the Supreme Court of NSW. 

The CDPP’s Library and Research Services team has won the 2022 Legal Information Service of the Year award announced at the Australian Law Librarians’ Association (ALLA) conference in Hobart on Thursday 26 August.

On 7 July 2022 the Commonwealth Attorney-General, the Honourable Mark Dreyfus QC MP, announced he had declined to proceed further in the prosecution of Mr Bernard Collaery for five offences relating to the alleged unlawful communication of ASIS information contrary to the Intelligence Services

On 11 February 2022, the Commonwealth Director of Public Prosecutions Ms Sarah McNaughton SC announced her decision to decline to proceed further in the criminal prosecutions of Citigroup Global Markets Australia Pty Limited, Deutsche Bank AG and four senior banking executives for cartel offences

The CDPP 2020-21 Annual Report was tabled in Parliament on Wednesday 20 October 2021. 

Drug Manufacture

Under the Criminal Code, manufacturing a controlled drug for a commercial purpose is an offence.

Manufacturing a controlled drug means any process—other than cultivation—that produces a drug. It includes extracting or refining and the process of transforming a substance into a different substance or drug. A person can also be involved in manufacturing a drug if they exercise control or direction over its manufacture or finance its manufacture.

A person manufactures a substance for a commercial purpose, if they manufacture a drug with the intention of selling it or believing that someone else intends to sell it. As a result manufacturing controlled drugs for personal use is not regulated by the Criminal Code.

Key legislation

Main offences

  • s.305.5 Criminal Code—manufacturing controlled drugs
  • s.308.4(1) Criminal Code—possessing a substance, equipment or instructions for commercial manufacture of controlled drugs.

Penalties

  • The maximum penalty for manufacturing a controlled drug is 10 years’ imprisonment or 12 years for an aggravated offence. The maximum penalty increases to 25 years if it involves a marketable quantity of drugs and life imprisonment for a commercial quantity of drugs
  • An offence against sections 305.4 or 305.5 is aggravated if the commission of the offence exposes a child (under 14 years) to the manufacture of a controlled drug (s.310.4)
  • The maximum penalty for possessing a substance, equipment or instructions for commercial manufacture of controlled drugs is 7 years’ imprisonment.

Partner agencies

Relevant Legislation